Pharmaceutical - Pharmaceutical, North America, Legal

Filter

1 to 25 of 157 results

Lilly's Alimta patent upheld through 2022

Lilly's Alimta patent upheld through 2022

01-04-2014

US pharma major Eli Lilly says that the US District Court for the Southern District of Indiana has ruled…

AlimtaEli LillyLegalNorth AmericaOncologyPatentsPharmaceuticalTeva Pharmaceutical IndustriesUSA

US Supreme Court agrees to hear Teva’s Copaxone patent appeal

US Supreme Court agrees to hear Teva’s Copaxone patent appeal

01-04-2014

Israel’s Teva Pharmaceutical Industries, the world largest generic drugmaker, says that the US Supreme…

CopaxoneLegalNeurologicalNorth AmericaPatentsPharmaceuticalTeva Pharmaceutical IndustriesUSA

Pfizer to appeal Court decision on Celebrex reissue patent

Pfizer to appeal Court decision on Celebrex reissue patent

13-03-2014

US pharma behemoth Pfizer confirmed today that the US District Court for the Eastern District of Virginia…

Anti-Arthritics/RheumaticsCelebrexLegalNorth AmericaPatentsPfizerPharmaceuticalUSA

Record-breaking recoveries from US DoJ/HHS joint efforts to combat health care fraud

27-02-2014

US Attorney General Eric Holder and Health and Human Services Secretary Kathleen Sebelius have released…

FinancialHealthcareLegalNorth AmericaPharmaceuticalUSA

Forest Labs files law suit against several drugmakers for Namenda XR patent infringement

02-02-2014

US drugmaker Forest Laboratories, together with Merz Pharma and Adamas Pharmaceuticals, has filed a law…

Adamas PharmaceuticalsForest LaboratoriesLegalMerz PharmaceuticalsNamendaNeurologicalNorth AmericaPatentsPharmaceuticalSun Pharmaceutical IndustriesTeva Pharmaceutical IndustriesUSAWockhardt

Sanofi sues Eli Lilly over Lantus patent infringement

Sanofi sues Eli Lilly over Lantus patent infringement

31-01-2014

French drug major Sanofi says it has filed a patent infringement suit against USA pharma firm Eli Lilly…

BiosimilarsDiabetesEli LillyLantusLegalNorth AmericaPatentsPharmaceuticalSanofiUSA

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade

10-01-2014

Swiss drug major Novartis faced two problems yesterday, when the Japanese Ministry of Health Labor and…

Asia-PacificCardio-vascularDiovanExjadeHematologyLegalMarkets & MarketingNorth AmericaNovartisPharmaceuticalUSA

Abbott Labs pays $5.5 million to settle claims it paid kickbacks to US physicians

Abbott Labs pays $5.5 million to settle claims it paid kickbacks to US physicians

29-12-2013

US drugmaker Abbott Laboratories has agreed to pay $5.475 million to resolve allegations that it violated…

LegalMarkets & MarketingNorth AmericaPharmaceuticalUSA

US House Budget bill passes, which would also free up FDA user fees

US House Budget bill passes, which would also free up FDA user fees

14-12-2013

The US House of Representatives Budget Committee Chairman Paul Ryan and Senate Budget Committee Chairman…

FinancialLegalNorth AmericaPharmaceutical

United Therapeutics subpoenaed over drug marketing practices

09-12-2013

US drugmaker United Therapeutics says it has received a subpoena from the Office of the Inspector General…

AdcircaLegalMarkets & MarketingNorth AmericaPharmaceuticalRemodulinTyvasoUnited Therapeutics

AHF sues Abbott and AbbVie for overcharging on AIDS drug pricing

AHF sues Abbott and AbbVie for overcharging on AIDS drug pricing

28-11-2013

In further legal action against drugmakers allegedly over pricing AIDS drugs in the USA, the AIDS Healthcare…

Abbott LaboratoriesAbbVieAnti-viralsKaletra TabletsLegalNorth AmericaNorvirPharmaceuticalPricing

J&J unit DePuy in $2.5 billion US settlement relating to ASR Hip System

20-11-2013

US health care giant Johnson & Johnson’s subsidiary DePuy Orthopaedics and the Court-appointed committee…

DePuyFinancialJohnson & JohnsonLegalNorth AmericaPharmaceutical

Drug Quality and Security Act passes in US Senate

20-11-2013

After months of discussion in the US Congress, finally HR 3204, the Drug Quality and Security Act, which…

LegalMarkets & MarketingNorth AmericaPharmaceuticalProduction

FTC highlights focus on health care markets competition before Judiciary subcommittee

17-11-2013

The USA’s Federal Trade Commission described its ongoing efforts to protect competition and consumers…

HealthcareLegalMergers & AcquisitionsNorth AmericaPharmaceutical

US FTC finalizes amendments to the premerger notification rules on patent right transfers

07-11-2013

The US Federal Trade Commission yesterday (November 6) issued final changes to the premerger notification…

LegalMergers & AcquisitionsNorth AmericaPatentsPharmaceutical

Johnson & Johnson to pay over $2.2 billion to settle DoJ probe

Johnson & Johnson to pay over $2.2 billion to settle DoJ probe

05-11-2013

Global health care giant Johnson & Johnson and its subsidiaries will pay more than $2.2 billion to resolve…

FinancialInvegaJanssenJohnson & JohnsonLegalMarkets & MarketingNatrecorNorth AmericaPharmaceuticalRisperdalScios

AHF sues Johnson & Johnson over AIDS drug pricing

AHF sues Johnson & Johnson over AIDS drug pricing

01-11-2013

The Washington DC, USA-based AIDS Healthcare Foundation (AHF) has filed a law suit in the Superior Court…

Anti-viralsJanssenJohnson & JohnsonLegalNorth AmericaPharmaceuticalPricing

Valeant agrees $142.5 million settlement with Anacor

28-10-2013

Anacor Pharmaceuticals says it has entered into a $142,5 million settlement agreement with Canada-based…

Anacor PharmaceuticalsFinancialLegalNorth AmericaPharmaceuticalValeant Pharmaceuticals

Anacor Pharma awarded $100 million damages

18-10-2013

Anacor Pharmaceuticals says that the arbitrator appointed to resolve its dispute with Canada-based Valeant…

Anacor PharmaceuticalsLegalNorth AmericaPharmaceuticalValeant Pharmaceuticals

CSL settles US antitrust class action litigation

CSL settles US antitrust class action litigation

09-10-2013

Australian blood products and vaccine maker CSL has signed an agreement to settle the US antitrust class…

CSL LimitedFinancialHematologyLegalNorth AmericaPharmaceutical

US Appeals Court lifts temporary injunction on Hanmi Nexium generic NDA

03-10-2013

AstraZeneca said that the US Court of Appeals for the Federal Circuit (CAFC) lifted a temporary injunction…

AstraZenecaEsomeprazole MagnesiumGastro-intestinalsHanmi PharmaceuticalLegalNexiumNorth AmericaPharmaceuticalRegulation

US Appeals Court reverses 2012 decision on Lovaza, clearing way for generics

13-09-2013

Reversing a district court decision last year (The Pharma Letter May 30, 2012), the US Court of Appeals…

AmarinCardio-vascularGenericsGlaxoSmithKlineLegalLovazaNorth AmericaPar PharmaceuticalsPatentsPharmaceuticalTeva Pharmaceutical IndustriesVascepa

AHF sues GSK for failing to provide discounts on HIV/AIDS drugs

11-09-2013

The USA-based AIDS Healthcare Foundation (AHF) said yesterday (September 10) that it has filed a law…

Anti-viralsGlaxoSmithKlineLegalNorth AmericaPharmaceuticalPricing

Avanir Pharma patent settlement with Wockhardt

08-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with the US unit…

Avanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceuticalWockhardt

1 to 25 of 157 results

Back to top